%3Amax_bytes(150000)%3Astrip_icc()%3Afocal(598x0%3A600x2)%2Fwoman-sues-ozempic-manufacturer-0905024-5388f138f9a04e62b8f50b1b47313ea0.jpg)
Legal Action and Health Consequences
Juanita Gantt, after being prescribed and Wegovy for weight loss and diabetes prevention, underwent emergency surgery and now uses an ileostomy bag, claiming insufficient warning about serious side effects.
Gantt's lawsuit against alleges the drug labels fail to adequately inform about risks like gastroparesis and bowel obstruction, contrasting with the company's defense that its products are safe when used as directed.
Public and Medical Perspectives
Despite the lawsuit, GLP-1 drugs like Ozempic and Wegovy are viewed by many in the medical community as transformative for weight loss and diabetes management, albeit with awareness of potential side effects.
The drugs have gained popularity for weight loss among Americans, with significant off-label use, raising concerns about the adequacy of existing warnings and the need for more comprehensive patient education.